PTC Therapeutics, Inc.  announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarnatm (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne ...

Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers. The ...

Our current approach to mental health labelling and diagnosis has brought benefits. But as a practising doctor, I am concerned that it may be doing more harm than good ...

Tom Nolan reviews this week’s research The long lists of side effects on summaries of product characteristics (SmPCs) are based mainly on non-randomised and non-blinded studies, which might be subject ...

Following a landmark ruling affirming the validity of Research and Development (R&D) credit claims for crop producers, the U.S. Tax Court has now confirmed that innovations in livestock production ...

Inside the lab where scientists want to rewrite our DNA from scratch - Artificial biological intelligence could change humanity forever. Chris Stokel-Walker reports ...

PBS NC helps your community explore new worlds and ideas through programs that educate, inform and inspire. Your ...

Prenatal exposure to PPIs and H2 receptor antagonists were not found to increase risk for neuropsychiatric disorders in offspring.

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

The registrations for NEET 2026 have commenced. In order to appear for the MBBS entrance test, the candidates need to be well aware of the syllabus for the test. The National ...